Corifolitropin-Alfa plus Five Days Letrozole Versus Daily Recombinant-FSH in Expected Normo-Responder Patients: A Retrospective Comparative Study

Background: In recent times, different novel GnRH-antagonist protocols with various combinations of gonadotropins and other molecules (e.g., aromatase inhibitors, selective estrogen receptor modulators) have been proposed for expected normal ovarian responders undergoing assisted reproductive treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Amato, Giuseppe, Caringella, Anna Maria, Stanziano, Antonio, Cantatore, Clementina, D’Amato, Antonio, Cicinelli, Ettore, Vitagliano, Amerigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092944/
https://www.ncbi.nlm.nih.gov/pubmed/37046467
http://dx.doi.org/10.3390/diagnostics13071249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092944/
https://www.ncbi.nlm.nih.gov/pubmed/37046467
http://dx.doi.org/10.3390/diagnostics13071249

Ejemplares similares